Laboratory, Microscopy & Medical Research · K01

Cell, Colony and Microorganism Object Counting

JIVISION offers project development and technical assessment for Cell, Colony and Microorganism Object Counting. Scope: Cell/colony/microbial objects, counts, areas, morphology and density.

Scope and project-specific requirements

Task / output

Cell/colony/microbial objects, counts, areas, morphology and density

Critical decision conditions

Reference counts must define touching and boundary objects; research counts must not become patient-test conclusions.

Candidate technical approach

These are candidate implementation paths. Establish a baseline on real samples, then select or combine methods for imaging, speed and deployment constraints. Model names do not imply measured project results.

Microscopic-object analysis

Flat-field or stain normalization → thresholding/watershed or U-Net/instance segmentation → counting, tracking and morphology

Inputs for assessment

Provide authorized, de-identified data, device/staining/acquisition protocols, the research protocol, expert annotations, independent batch or participant splits and ethics requirements.

Deliverables and interface agreement

Result schema, algorithm or processing configuration, example outputs and evaluation records for: Cell/colony/microbial objects, counts, areas, morphology and density. Software format and source-code scope are agreed in the contract.

Specify input formats, output fields, coordinates/units, error states, versions and invocation methods. Define review and failure handling. The statement of work determines the exact scope of source code, executables, model files or analysis reports.

Acceptance method and measures

Task-specific acceptance measures

Count MAE; object F1; split/merge rate

Prevent participant or source-slide leakage across training/test sets. Record annotation agreement, stratified metrics, failure cases and reproducibility parameters; use traceable references for laboratory measurements.

These are measures to agree and test, not achieved-performance claims. Freeze samples, reference truth, thresholds and hardware/software versions before acceptance; report subgroup results and failures, identifying under-sampled conditions as uncovered.

Implementation and procurement stages

  1. Define scope

    Agree targets, stations, inputs and responsibilities in a statement of work, separating required and excluded conditions.

  2. Sample validation

    Use representative samples to test critical risks, document feasibility/failures and scope the next-stage estimate.

  3. Development and integration

    Implement agreed functions and interfaces with configuration/change records; use offline replay before authorized device or site integration.

  4. Acceptance and handover

    Retest against individual measures and hand over contracted artifacts with known limits; manage maintenance, expansion and changeovers as subsequent work packages.

Scope limits and licensing

For laboratory automation and research analysis, not disease diagnosis, screening, treatment decisions or medical-device performance claims. Clinical use requires separate applicable validation and approvals.

Candidate technologies are not license clearance. Check code, model weights, training data and dependency versions separately. Replace, license or exclude components unsuitable for the intended commercial delivery. Customer data is not used for public training by default.

Project FAQs

What does this service produce?

Cell/colony/microbial objects, counts, areas, morphology and density. Deliverables: Result schema, algorithm or processing configuration, example outputs and evaluation records for: Cell/colony/microbial objects, counts, areas, morphology and density. Software format and source-code scope are agreed in the contract.

What needs to be confirmed first?

Reference counts must define touching and boundary objects; research counts must not become patient-test conclusions.

How is acceptance defined beyond a demonstration?

Task-specific measures: Count MAE; object F1; split/merge rate. Prevent participant or source-slide leakage across training/test sets. Record annotation agreement, stratified metrics, failure cases and reproducibility parameters; use traceable references for laboratory measurements.

How are cost and schedule assessed?

After reviewing samples for cell/colony/microbial objects, counts, areas, morphology and density, equipment conditions and interfaces, scope validation, development, deployment and acceptance separately. Data coverage, site changes and delivery rights affect the estimate; no fixed performance or schedule is promised before assessment.

PROJECT INQUIRY

Discuss this service for your project

Service ID: K01 · Cell, Colony and Microorganism Object Counting

Describe available samples, equipment and target measures. Agree confidentiality and permissions before transferring sensitive or personal data through an approved channel.

+86 13910119357
xuzhiyang0928@gmail.com

Submitted information is for this project inquiry. Do not include sensitive information without authorization.